You're A Small Biotech — How Should You Implement A P

You're A Small Biotech — How Should You Implement A Pharmacovigilance System


You're A Small Biotech — How Should You Implement A Pharmacovigilance System?
By Steve Knowles, chief medical officer, Halozyme Therapeutics
Learnings on how to implement drug safety protocols effectively

both time-wise and cost-wise
When it comes to implementing strong pharmacovigilance (PV) practices at your company, there are a variety of components and capabilities that will be necessary to put in place. Having worked in this space for the majority of my pharmaceutical industry career, I know that it can be incredibly difficult to understand the intricacies of integrating these processes — especially with a constantly shifting regulatory landscape. The task can be quite daunting.

Related Keywords

Steve Knowles , Development Safety Update Report , Big Pharma , ஸ்டீவ் நோல்ஸ் , வளர்ச்சி பாதுகாப்பு புதுப்பிப்பு அறிக்கை , பெரியது பார்மா ,

© 2025 Vimarsana